介绍

本页面提供了有关 Eric Andersen 已知的内部交易历史的全面分析。内部人士包括公司的高管、董事或重要投资者。一般而言,基于内幕、非公开信息进行交易是非法的。这并不意味着他们在自己的公司进行任何交易都是非法的。但是,他们必须通过Form 4向美国证券交易委员会(SEC)报告所有交易。尽管存在这些限制,学术研究表明,整体而言,内部人士在自己公司中的投资表现往往优于市场。

平均交易盈利能力

“平均交易盈利能力”衡量了内部人士在过去三年中所有非计划性的公开市场买入交易的平均回报率。计算过程包括检查每笔交易,排除了作为10b5-1交易计划的一部分的交易。然后,对每笔交易在3、6和12个月的表现进行平均,以生成该笔交易最终的表现指标。然后,将所有交易的表现指标进行平均,计算出内部人士的总体平均表现指标。列表仅包含在过去两年中进行过至少三笔交易的内部人士。

如果内部人士的交易盈利能力显示为"N/A",则可能是因为该内部人士在过去三年内没有进行任何公开市场买入交易,或者他们进行的交易距离现在时间太近,无法计算出可靠的表现指标。

更新频率:每日

查看收益最高的的内幕交易者列表。

报告内部持仓的公司

美国证券交易委员会(SEC)文件显示Eric Andersen已报告在以下公司拥有持仓或进行了交易:

证券 职位 最新报告的持仓
US:MACK / Merrimack Pharmaceuticals, Inc. Director 534,008
如何解读这些图表

以下图表显示了在Eric Andersen进行的每笔公开市场非计划交易后证券的股价表现。非计划交易是指没有作为10b5-1交易计划的一部分而进行的交易。股价表现以累积百分比变化的方式绘制。例如,如果一笔内部人士交易是在2019年1月1日进行的,该图表将显示该证券的每日百分比变化直至当前日期。如果在此期间股价从10美元涨至15美元,则股价的累积百分比变化将为50%。从10美元涨至20美元的价格变化将为100%,而从10美元跌至5美元的价格变化将为-50%。

最终,我们将评估内部人士的交易与股价的超额回报(正向或负向)之间的相关性,以判断内部人士是否在交易中利用内部信息获利。如果内部人士有这样的行为,我们预期看到(a)买入后的正回报,或者(b)卖出后的负回报。对于情况(a),买入图表将显示一系列向上倾斜的曲线,表示每次买入后都有正回报。对于情况(b),卖出图表将显示一系列向下倾斜的曲线,表示每次卖出后都有负回报。

然而,仅凭这一点还不足以得出结论。例如,如果公司的股价在多年内呈现非周期性上升,我们会预期所有买入后的图表都呈现向上倾斜。同样地,多年来呈现非周期性下降的股价会导致卖出后的图表也呈现向下倾斜。这两种情况的图表都不能表示内部人士在进行内幕交易。

最有力的指标是在公司股价呈极度循环波动的情况下,“买入”图表显示正向信号,而“卖出”图表显示负向趋势。这种情况强烈暗示内部人士可能根据内幕信息精确地计时进行交易,以获得财务优势。

内幕交易历史

该表格显示了由 Eric Andersen 进行的所有内幕交易的完整列表,这些交易已向美国证券交易委员会(SEC)披露。

备案日期 交易日期 表格 股票代码 证券 代码 10b5-1 股数 剩余股数 %
变化
每股
股价
交易
金额
剩余
金额
2023-12-28 2023-12-28 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 857 534,008 0.16 13.35 11,441 7,129,167
2023-12-28 2023-12-26 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 48,693 533,151 10.05 13.15 640,313 7,010,936
2023-12-11 2023-12-07 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 24,666 484,458 5.36 12.85 316,953 6,225,188
2023-12-11 2023-12-07 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 76,384 1,735,600 4.60 12.85 981,519 22,302,113
2023-11-20 2023-11-17 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 65 459,792 0.01 12.50 812 5,747,400
2023-11-20 2023-11-17 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 235 1,659,216 0.01 12.50 2,938 20,740,200
2023-11-16 2023-11-14 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 10,887 459,727 2.43 12.50 136,088 5,746,588
2023-11-16 2023-11-14 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 39,283 1,658,981 2.43 12.50 491,038 20,737,262
2023-11-14 2023-11-13 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 3,379 448,840 0.76 12.39 41,858 5,560,050
2023-11-14 2023-11-13 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 12,191 1,619,698 0.76 12.39 151,017 20,064,171
2023-11-14 2023-11-10 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 8,259 445,461 1.89 12.32 101,769 5,489,060
2023-11-14 2023-11-10 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 29,803 1,607,507 1.89 12.32 367,239 19,808,023
2023-11-13 2023-11-09 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 2,165 437,202 0.50 12.19 26,396 5,330,498
2023-11-13 2023-11-09 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 7,810 1,577,704 0.50 12.19 95,222 19,235,840
2023-11-13 2023-11-08 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 9,040 435,037 2.12 12.13 109,673 5,277,869
2023-11-13 2023-11-08 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 4,783 1,569,894 0.31 12.13 58,027 19,045,954
2023-08-09 2023-08-08 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 18,626 425,997 4.57 12.00 223,436 5,110,217
2023-08-09 2023-08-08 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 68,431 1,565,111 4.57 12.00 820,891 18,774,915
2023-08-09 2023-08-07 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 49,857 407,371 13.95 12.00 598,468 4,889,959
2023-08-09 2023-08-07 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 84,636 1,496,680 5.99 12.00 1,015,945 17,965,698
2023-03-22 2023-03-21 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 33,181 357,514 10.23 11.52 382,245 4,118,561
2023-03-22 2023-03-21 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 127,409 1,412,044 9.92 11.52 1,467,752 16,266,747
2023-03-01 2023-01-31 4/A MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 450 324,333 0.14 11.40 5,130 3,697,331
2023-03-01 2023-01-31 4/A MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 1,782 1,284,635 0.14 11.40 20,314 14,644,582
2023-03-01 2023-01-30 4/A MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 4,985 323,883 1.56 11.36 56,618 3,678,534
2023-03-01 2023-01-30 4/A MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 19,750 1,282,853 1.56 11.36 224,313 14,570,131
2023-02-01 2023-01-31 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 450 324,306 0.14 11.40 5,130 3,697,024
2023-02-01 2023-01-31 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 1,782 1,284,635 0.14 11.40 20,314 14,644,582
2023-02-01 2023-01-30 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 4,958 323,856 1.55 11.36 56,311 3,678,227
2023-02-01 2023-01-30 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 19,750 1,282,853 1.56 11.36 224,313 14,570,131
2023-01-31 2023-01-27 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 4,410 318,898 1.40 11.40 50,259 3,634,321
2023-01-31 2023-01-27 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 17,465 1,263,103 1.40 11.40 199,040 14,394,953
2023-01-04 2023-01-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 8,219 314,488 2.68 11.33 93,148 3,564,155
2023-01-04 2023-01-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 22,413 1,245,638 1.83 11.33 254,011 14,117,065
2023-01-03 2022-12-30 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 8,270 306,269 2.78 11.33 93,721 3,470,855
2023-01-03 2022-12-30 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 33,030 1,223,225 2.78 11.33 374,319 13,862,442
2023-01-03 2022-12-29 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 28,661 297,999 10.64 10.55 302,382 3,143,979
2023-01-03 2022-12-29 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 189,975 1,190,195 18.99 10.55 2,004,293 12,556,914
2021-09-20 2021-07-01 4/A MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
S - Sale -52,914 269,338 -16.42 6.39 -338,120 1,721,070
2021-09-20 2021-07-01 4/A MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 52,914 1,000,220 5.59 6.39 338,120 6,391,406
2021-09-20 2021-04-14 4/A MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 6,495 322,252 2.06 6.63 43,081 2,137,465
2021-09-20 2021-04-14 4/A MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 40,805 947,306 4.50 6.63 270,655 6,283,386
2021-04-16 2021-04-14 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 6,495 322,252 2.06 6.63 43,081 2,137,465
2021-04-16 2021-04-14 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 40,805 947,396 4.50 6.63 270,655 6,283,983
2021-04-15 2021-04-13 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 9,874 906,591 1.10 6.26 61,780 5,672,359
2021-04-14 2021-04-12 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 23,629 896,717 2.71 6.06 143,194 5,434,195
2020-11-27 2020-11-24 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 18,014 315,757 6.05 3.65 65,751 1,152,513
2020-11-27 2020-11-24 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 51,074 873,088 6.21 3.65 186,420 3,186,771
2020-11-16 2020-11-12 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 54,531 297,743 22.42 3.65 199,038 1,086,762
2020-11-16 2020-11-12 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 1,959 822,014 0.24 3.65 7,150 3,000,351
2020-08-17 2020-08-13 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 609 820,055 0.07 3.50 2,132 2,870,192
2020-08-13 2020-08-12 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 2,000 243,212 0.83 3.49 6,986 849,540
2020-08-13 2020-08-11 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 14,030 241,212 6.18 3.45 48,437 832,760
2020-07-24 2020-07-22 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 33,192 227,182 17.11 3.04 100,967 691,065
2020-07-24 2020-07-22 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 17,404 193,990 9.86 3.20 55,728 621,156
2020-07-24 2020-07-22 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 63,903 819,446 8.46 3.04 194,387 2,492,673
2020-07-24 2020-07-22 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 62,775 755,543 9.06 3.20 201,006 2,419,249
2020-04-22 2020-04-21 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 1,424 692,768 0.21 3.25 4,628 2,251,496
2020-04-22 2020-04-20 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 2,325 691,344 0.34 3.25 7,556 2,246,868
2020-04-08 2020-04-07 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 5,899 689,019 0.86 3.03 17,885 2,088,968
2020-04-07 2020-04-06 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 6,043 683,120 0.89 3.00 18,108 2,046,969
2020-04-07 2020-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 10,750 677,077 1.61 2.60 27,924 1,758,775
2019-09-27 3 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
1,509,240
2019-09-27 3 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
1,019,499
2019-09-27 3 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
1,509,240
2019-09-27 3 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
1,019,499
2019-09-27 3 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
1,509,240
2019-09-27 3 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
1,019,499
2019-09-27 3 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
1,509,240
2019-09-27 3 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
1,019,499
2019-09-27 3 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
1,509,240
2019-09-27 3 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
1,019,499
2019-09-27 3 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
1,509,240
2019-09-27 3 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
1,019,499
P
非衍生或衍生证券的公开市场或私下买入
S
非衍生或衍生证券的公开市场或私下卖出
A
公司向内部人员授予、奖励或以其他方式获取证券(例如股票期权)
C
衍生工具转换
D
将证券卖出或转让回公司
F
使用从公司收到的证券的一部分来支付行使价或税务负担。
G
内部人士赠送或接收他人赠送公司股票
K
股权掉期和类似的避险交易
M
行使或转换从公司获得的衍生证券(例如期权)
V
内部人士通过Form 4自愿报告的一笔交易
J
其他(附有交易描述的脚注)